No Data
ALC Alcon
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Alcon Company
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.
Revenue Breakdown
News
Orbis International Teams Up With the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
The Orbis Flying Eye Hospital returns to Zambia for a three-week training project in Lusaka coinciding with World Sight Day on October 12LUSAKA, Zambia, Sept. 25, 2023 /PRNewswire/ -- Global eye care
Here's Why Investors Should Buy Alcon (ALC) Stock Right Now
Top Gap Ups and Downs on Tuesday: TM, TTE, INTU and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Comments
ColumnsToday's Pre-Market Stock Movers: ABNB, RIVN, AFRM, SPCE and More
$Rivian Automotive(RIVN.US$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...

ColumnsUS Top Rating Updates on 5/10: PYPL, EXAS, CELH, GTLB and More
$Exact Sciences(EXAS.US$ Price Target Raised to $85.00/Share From $55.00 by Craig-Hallum.
Baird Upgrades Alcon to Outperform, Raises Price Target to $90
Baird analyst Jeff Johnson upgrades $Alcon(ALC.US$ from Neutral to Outperform and raises the price target from $75 to $90.
BofA Securities Upgrades Celsius Holdings to Buy, Raises Price Target to $125
B o...

ColumnsUS Top Gap Ups and Downs on 5/3: AMD, VOD, SBUX, EL and More
Gap Ups
1. $Unum Group(UNM.US$ - up 5.1%
2. $Generac(GNRC.US$ - up 5.0%
3. $Builders FirstSource(BLDR.US$ - up 4.9%
4. $Livent(LTHM.US$ - up 4.4%
5. $Pearson(PSO.US$ - up 4.1%
6. $Verisk Analytics(VRSK.US$ - up 3.6%
7. $Assurant(AIZ.US$ - up 2.7%
8. $Vodafone(VOD.US$ - up...


